The aim of this study was to investigate the impact of the PSP risk allele (APOEε2) and the AD risk allele (APOEε4) on astrocytic tau accumulation, tau spreading, tau-mediated inflammation and neurodegeneration, using isogenic human iPSC derived astrocytes. The gene discussed is MAPT; the disease is Alzheimer disease.